ACUPOINT INJECTION THERAPY USING AN ENRICHED CELLULAR MIXTURE
First Claim
Patent Images
1. A method for treating a particular organ or region of a patient, comprising the steps of:
- obtaining a stem cell/platelet-rich-plasma (PRP) mixture from the patient;
identifying a particular meridian associated with the particular organ or region to be treated; and
injecting the enhanced stem cell/PRP mixture into at least one acupoint on the identified meridian.
1 Assignment
0 Petitions
Accused Products
Abstract
A system and method are provided that use the meridian flow defined in traditional Chinese medicine to target specific regions of the body to treat certain health conditions. A cellular mixture is injected into the body via an acupoint on a particular meridian in order to deliver the mixture to an organ or body region associated with the particular meridian. The cellular mixture can be a stem cell/PRP mixture.
-
Citations
20 Claims
-
1. A method for treating a particular organ or region of a patient, comprising the steps of:
-
obtaining a stem cell/platelet-rich-plasma (PRP) mixture from the patient; identifying a particular meridian associated with the particular organ or region to be treated; and injecting the enhanced stem cell/PRP mixture into at least one acupoint on the identified meridian. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A method of preparing an enhanced stem cell/PRP mixture for treatment of a particular organ or region of a patient, comprising the steps of:
-
obtaining a stem cell/PRP mixture from the patient; and enhancing the obtained stem cell/PRP mixture by subjecting the stem cell/PRP mixture to at least one specific bio-frequency associated with the particular organ or region of the patient. - View Dependent Claims (11, 12, 13, 14)
-
-
15. A method of treating a particular organ or region of a patient, comprising the steps of:
-
obtaining a first stem cell/PRP mixture from the patient; injecting the first stem cell/PRP mixture into the circulatory system of the patient; obtaining a second stem cell/PRP mixture from the patient; and injecting at least a portion of the second stem cell/PRP mixture into at least one acupoint of the patient along a meridian associated with the particular organ or region to be treated. - View Dependent Claims (16, 17, 18, 19, 20)
-
Specification